share_log

Eiger BioPharmaceuticals | 3: Initial statement of beneficial ownership of securities-10% Owner KAWAS LEEN

Eiger BioPharmaceuticals | 3: Initial statement of beneficial ownership of securities-10% Owner KAWAS LEEN

Eiger BioPharmaceuticals | 3:首次持股聲明-股東 KAWAS LEEN
美股sec公告 ·  2023/10/30 16:51
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息